# EDGAR Filing Document

**Accession Number:** 0001992761
**File Stem:** 0001193125-26-149609
**Filing Date:** 2026-4
**Character Count:** 6355
**Document Hash:** f1f0772ace20f77eb720e11022063e05
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-149609.hdr.sgml**: 20260409

**ACCESSION NUMBER**: 0001193125-26-149609

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260318

**FILED AS OF DATE**: 20260409

**DATE AS OF CHANGE**: 20260409

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Windels Hilde
- **CENTRAL INDEX KEY:** 0001992761

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40996
- **FILM NUMBER:** 26851610

**MAIL ADDRESS:**
- **STREET 1:** C/O PHAXIAM THERAPEUTICS S.A.
- **STREET 2:** 60, AVENUE ROCKEFELLER, BATIMENT ADENINE
- **CITY:** LYON
- **STATE:** I0
- **ZIP:** 69008
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MDxHealth SA
- **CENTRAL INDEX KEY:** 0001872529
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MEDICAL LABORATORIES [8071]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** C9

**BUSINESS ADDRESS:**
- **STREET 1:** CAP BUSINESS CENTER
- **STREET 2:** RUE D'ABHOOZ, 31, B-4040
- **CITY:** HERSTAL
- **STATE:** C9
- **ZIP:** 00000
- **BUSINESS PHONE:** 949-271-9221

**MAIL ADDRESS:**
- **STREET 1:** CAP BUSINESS CENTER
- **STREET 2:** RUE D'ABHOOZ, 31, B-4040
- **CITY:** HERSTAL
- **STATE:** C9
- **ZIP:** 00000

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MDx Health SA
- **DATE OF NAME CHANGE:** 20210713

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Windels Hilde<br><sub>(Last) (First) (Middle)</sub><br>CAP BUSINESS CENTER<br>ZONE INDUSTRIELLE DES HAUTS-SARTS<br><sub>(Street)</sub><br>HERSTAL, BELGIUM 4040<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>MDxHealth SA [ MDXH ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2026-03-18 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director   [ ] 10% Owner<br>[ ] Officer (give title below)   [ ] Other (specify below)<br>_ _ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Share Option | <sup>(1)</sup> | 2028-06-01 | Ordinary Shares | 1000 | <sup>(1)</sup> | I | By Hilde Windels BV<sup>(2)</sup> |
| Share Option | <sup>(3)</sup> | 2029-07-01 | Ordinary Shares | 1000 | <sup>(3)</sup> | I | By Hilde Windels BV<sup>(2)</sup> |
| Share Option | <sup>(4)</sup> | 2034-06-22 | Ordinary Shares | 30000 | $2.62 | I | By Hilde Windels BV<sup>(2)</sup> |
| Share Option | <sup>(5)</sup> | 2035-06-27 | Ordinary Shares | 10000 | $2.18 | I | By Hilde Windels BV<sup>(2)</sup> |

---

### Footnotes:

(1) Represents options to purchase 1,000 ordinary shares of the Issuer at a price per share of 49.70 Euros granted on June 1, 2018 which vested in full on the date of the annual general shareholders' meeting that took place in the calendar year following the calendar year in which the options were granted.

(2) Shares held by Hilde Windels BV may be deemed to be beneficially owned by the Reporting Person as the Managing Director of Hilde Windels BV.  The Reporting Person disclaims beneficial ownership of the securities held by Hilde Windels BV other than to the extent that she may have a pecuniary interest therein.

(3) Represents options to purchase 1,000 ordinary shares of the Issuer at a price per share of 12.80 Euros granted on July 1, 2019 which vested in full on the date of the annual general shareholders' meeting that took place in the calendar year following the calendar year in which the options were granted.

(4) Represents options to purchase 30,000 ordinary shares of the Issuer at a price per share of $2.62 granted on June 22, 2024 which vested in full on the date of the annual general shareholders' meeting that took place in the calendar year following the calendar year in which the options were granted.

(5) Represents options to purchase 10,000 ordinary shares of the Issuer at a price per share of $2.18 granted on June 27, 2025 which vest in full on the date of the annual general shareholders' meeting that takes place in the calendar year following the calendar year in which the options were granted.

**Signature:** /s/ Mark Busch, as attorney-in-fact for Hilde Windels  
**Date:** 2026-04-09

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**